Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Kryptofix 22 dd | Kryptofix 22 dd. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Kryptofix 22dd, Kryptofix 22 DD, 36760_ALDRICH, 36760_FLUKA, MolPort-003-931-086, CID72806, EINECS 279-168-4, NSC339326, NSC 339326, NCGC00166067-01, 1,10-Didecyl-1,10-diaza-18-crown-6, 7,16-Didecyl-1,4,10,13-tetraoxa-7,16-diaza-cyclooctadecane, 7,16-Didecyl-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane, 1,4,10,13-Tetraoxa-7,16-diazacyclooctadecane, 7,16-didecyl-, 79495-97-9. Product Category: Heterocyclic Organic Compound. CAS No. 79495-97-9. Molecular formula: C32H66N2O4. Mole weight: 542.88. Purity: 0.96. IUPACName: 7,16-didecyl-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane. Canonical SMILES: CCCCCCCCCCN1CCOCCOCCN(CCOCCOCC1)CCCCCCCCCC. Density: 0.897g/cm³. ECNumber: 279-168-4. Product ID: ACM79495979. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Kryptofix(r) 211 | Kryptofix(r) 211. Uses: Designed for use in research and industrial production. Additional or Alternative Names: cryptating agent 211. Product Category: Other Monomers. CAS No. 31250-06-3. Molecular formula: C14H28N2O4. Mole weight: 288.38 g/mol. Product ID: ACM-MO-31250063. Alfa Chemistry ISO 9001:2015 Certified. Categories: 4,7,13,18-tetraoxa-1,10-diazabicyclo[8.5.5]icosane. | |
| 1,13-Bis(8-quinolyl)-1,4,7,10,13-pentaoxatridecane | 1,13-Bis(8-quinolyl)-1,4,7,10,13-pentaoxatridecane. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 8,8-(1,4,7,10,13-PENTAOXATRIDECYLENE)-DIQUINOLINE;1,13-BIS(8-QUINOLYL)-1,4,7,10,13-PENTAOXATRIDECANE;KRYPTOFIX 5;KRYPTOFIX (R) 5;LABOTEST-BB LT00441375;TETRAETHYLENE GLYCOL BIS(8-QUINOLYL) ETHER;8,8'-[oxybis(ethyleneoxyethyleneoxy)]diquinoline;KRYPTOFIX. Product Category: Heterocyclic Organic Compound. CAS No. 57310-75-5. Molecular formula: C26H28N2O5. Mole weight: 448.51. Purity: 0.96. IUPACName: 8-[2-[2-[2-(2-quinolin-8-yloxyethoxy)ethoxy]ethoxy]ethoxy]quinoline. Canonical SMILES: C1=CC2=C(C(=C1)OCCOCCOCCOCCOC3=CC=CC4=C3N=CC=C4)N=CC=C2. Density: 1.208g/cm³. ECNumber: 260-674-9. Product ID: ACM57310755. Alfa Chemistry ISO 9001:2015 Certified. | |
| 1,4,7,10-Tetraazacyclododecane | 1,4,7,10-Tetraazacyclododecane. Uses: Macrocyclic aza analogue of the crown ether 12-crown-4. cyclen compounds are capable of selectively binding cations and are used as a ligand with chemicals used in mri contrast (as well ass other imaging) agents. Group: Macrocyclessupramolecular host materials monomers. Alternative Names: MLS000069489; Cyclen, 97%; AJ-75747; BP-21532; CHEBI:37391; KRYPTOFIX 11 AZA; EC 425-450-9; 964584YO2O; AM20090388; NCGC00018128-02. CAS No. 294-90-6. Product ID: 1,4,7,10-tetrazacyclododecane. Molecular formula: 172.276g/mol. Mole weight: C8H20N4. C1CNCCNCCNCCN1. InChI=1S / C8H20N4 / c1-2-10-5-6-12-8-7-11-4-3-9-1 / h9-12H, 1-8H2. QBPPRVHXOZRESW-UHFFFAOYSA-N. |  |
| 2,2,2-Cryptand (4, 7, 13, 16, 21, 24-Hexaoxa-1, 10-diazabicyclo[8. 8. 8]hexacosane) | 2,2,2-Crypt is used in the synthesis of hybrid metal-organic salts. It is also an impurity in the preparation of Fludeoxyglucose, a D-Glucose derivative used in the synthesis of sugar nucleotides and oligosaccharides. Group: Biochemicals. Alternative Names: 2,2,2-Cryptand; 2,2,2-Cryptate; Crypt-2,2,2; Cryptand 222; Cryptand C 222; Cryptand[2.2.2]; Cryptate 222; Cryptating agent 222; Cryptofix 222; K 222; Kryptand 222; Kryptofix 222; NSC 264495; [2,2,2]Crypand; USP Fludeoxyglucose Related Compound A. Grades: Highly Purified. CAS No. 23978-09-8. Pack Sizes: 10mg, 100mg. Molecular Formula: C??H??N?O?, Molecular Weight: 376.49. US Biological Life Sciences. |  Worldwide |
Our database is helping our users find suppliers everyday.
